88667306 - PARVULET

Information

• Trademark
• 88667306

• Source

• Serial Number

  88667306

• Registration Number

  6269377

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 24, 2019
  5 years ago

• Registration Date

  February 16, 2021
  3 years ago

• Transaction Date

  February 16, 2021
  3 years ago

• Status Date

  February 16, 2021
  3 years ago

• Published for Opposition Date

  December 01, 2020
  4 years ago

• Location Date

  February 16, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MCDORMAN, ROGER THOMAS

• Attorney Docket Number

  186380-5003

  Attorney Name

  Allison Z. Gifford

  Law Office Assigned Location Code

  L90

• Owners

  • ADARE PHARMACEUTICALS S.A.S

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, fever management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, inflammation, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, disbiosys, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes, namely, for the treatment of illnesses characterized by lack of such peptides and analogues thereof; vitamins; biologics being biopharmaceuticals and biologically active substances for the treatment of exocrine pancreatic insufficiency, cystic fibrosis; pharmaceutical and nutraceuticals preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral powder, oral liquids, oral suspensions, oral gels, and oral emulsions for the immediate or controlled, extended, delayed, pulsatile, local release release of a wide variety of therapeutic agents within a certain time after ingestion; oral powder for reconstitution, namely for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents within a certain time after ingestion; medical gel; medicated candy; medicated chewing gum; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds and nutraceuticals; drug delivery systems comprising polymer-based oral tablets, oral powder for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents; drug delivery agents for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, powder, emulsions; drug delivery powder for reconstitution in water before administration
• GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers in the nature of blister packs and sachets for various pharmaceuticals, drugs, medicines, compounds and substances sold without medication; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems, namely, drug delivery patches sold without medication, implantable drug delivery ports, intravenous bags sold empty for intravenous therapy
• GS0401: Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials for others
• GS0421: Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, fever management, inflammation, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, disbiosys diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research, design and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates and biologics; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines with improved compliance and acceptability by the patients; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like, gelling and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing solid dosage forms such as pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs and biologics; biochemical and molecular biological analyses of pharmaceuticals and nutraceuticals preparations to ensure efficacy and safety; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides or other biologics analogues for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs; preparation of materials for promotional documents and campaigns
• TR0010: The wording "PARVULET" has no meaning in a foreign language.

Case File Event Statements

• 2/16/2021 - 3 years ago

  23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/1/2020 - 4 years ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/1/2020 - 4 years ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/11/2020 - 4 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/26/2020 - 4 years ago

  19 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 10/23/2020 - 4 years ago

  18 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 10/19/2020 - 4 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/17/2020 - 4 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/16/2020 - 4 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/16/2020 - 4 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/23/2020 - 4 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/23/2020 - 4 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/23/2020 - 4 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/2/2020 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/2/2020 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/2/2020 - 4 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 6/22/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/3/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/3/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/3/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/30/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/30/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 10/28/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP